SEC 13F Intelligence

INVIVO THERAPEUTICS HLDGS CO COM

CUSIP 46186M407

Invivo Therapeutics Hldgs Co Com has 1 institutional holders in Filings Flow’s 13F database, together reporting 0 shares worth $0 as of Q2 2021.

Institutional Holders
1
Q2 2021
Reported Value
$0
Ticker
unmapped
private placement or foreign
Quarters Tracked
11

Ownership Trend

Institutional holders
Q4 ’18: 10Q4 ’18Q1 ’19: 13Q2 ’19: 11Q2 ’19Q3 ’19: 17Q4 ’19: 10Q4 ’19Q1 ’20: 2Q2 ’20: 1Q2 ’20Q3 ’20: 1Q4 ’20: 1Q4 ’20Q1 ’21: 1Q2 ’21: 1Q2 ’21filingsflow.com
Total reported value
Q4 ’18: $101,002Q4 ’18Q1 ’19: $283,002Q2 ’19: $96,001Q2 ’19Q3 ’19: $32,000Q4 ’19: $207,000Q4 ’19Q1 ’20: $0Q2 ’20: $0Q2 ’20Q3 ’20: $0Q4 ’20: $0Q4 ’20Q1 ’21: $0Q2 ’21: $0Q2 ’21filingsflow.com

Holders

Export to Excel
Manager% of PortfolioValueSharesQuarter
IFP Advisors, Inc$4.8B AUM—$00Q2 2021

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.